A Modular Self‐Assembling and Self‐Adjuvanting Multiepitope Peptide Nanoparticle Vaccine Platform to Improve the Efficacy and Immunogenicity of BCG
Small · 2025
DOI: 10.1002/smll.202406874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Guangzu Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute of Tropical Health and Medicine, James Cook University, Cairns & Townsville, QLD, 4878 & 4811, Australia. Hauptthemen laut MEDLINE: BCG Vaccine, Nanoparticles, Epitopes, Peptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Health and Medical Research Council, Australian Research Council.
Abstract (Originalsprache)
After more than a century since its initial development, Bacille Calmette‐Guérin (BCG) remains the only licensed vaccine against tuberculosis (TB). Subunit boosters are considered a viable strategy to enhance BCG efficacy, which often wanes in adolescence. While many studies on booster subunit vaccines have concentrated on recombinant proteins, here we developed a novel modular peptide‐based subunit vaccine platform that is flexible, cold‐chain independent and customizable to diverse circumstances and populations. Each individual peptide building block consists of a linear arrangement comprising a 15‐leucine self‐assembly inducer moiety, a Mycobacterium tuberculosis (Mtb) target epitope and an human leukocyte antigen E (HLA‐E) binding moiety, with each moiety separated by a triple lysine spacer. The building blocks, in any combination, are able to form a multiepitope nanoparticle. Six Mtb epitopes were selected to produce the self‐assembling and self‐adjuvating peptide‐based TB nano‐vaccine candidate PNx6. In vivo vaccination‐challenge experiments demonstrated that subcutaneous boost of parenteral BCG immunization with PNx6 significantly enhanced its immunogenicity and improved its protective efficacy in a murine model of TB by more than 5‐fold. This study presents evidence that purely amphiphilic peptides self‐assemble into self‐adjuvating nanoparticles with appropriate size and morphology for TB vaccination with great potential for a multitude of other diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Australian Institute of Tropical Health and Medicine, James Cook University, Cairns & Townsville, QLD, 4878 & 4811, Australia.
- School of Chemistry & Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia.
ORCID-Profile: Guangzu Zhao, Harindra D Sathkumara, Ana Maria Valencia-Hernandez, Munish Puri, Wenbin Huang, Istvan Toth, Norelle Daly, Mariusz Skwarczynski, Andreas Kupz
Förderung
- National Health and Medical Research Council
- Australian Research Council
Zitieren
APA
Zhao, G., Sathkumara, H. D., Miranda-Hernandez, S., Seifert, J., Valencia-Hernandez, A. M., Puri, M., Huang, W., Toth, I., Daly, N., Skwarczynski, M., & Kupz, A. (2025). A Modular Self‐Assembling and Self‐Adjuvanting Multiepitope Peptide Nanoparticle Vaccine Platform to Improve the Efficacy and Immunogenicity of BCG. Small. https://doi.org/10.1002/smll.202406874
Vancouver
Zhao G, Sathkumara HD, Miranda-Hernandez S, Seifert J, Valencia-Hernandez AM, Puri M, et al. A Modular Self‐Assembling and Self‐Adjuvanting Multiepitope Peptide Nanoparticle Vaccine Platform to Improve the Efficacy and Immunogenicity of BCG. Small. 2025. doi:10.1002/smll.202406874
BibTeX
@article{Zhao2025,
author = {Zhao, Guangzu and Sathkumara, Harindra D and Miranda-Hernandez, Socorro and Seifert, Julia and Valencia-Hernandez, Ana Maria and Puri, Munish and Huang, Wenbin and Toth, Istvan and Daly, Norelle and Skwarczynski, Mariusz and Kupz, Andreas},
title = {A Modular Self‐Assembling and Self‐Adjuvanting Multiepitope Peptide Nanoparticle Vaccine Platform to Improve the Efficacy and Immunogenicity of BCG},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202406874}
}
EUVIMED